GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (NAS:INMD) » Definitions » Debt-to-Equity

InMode (InMode) Debt-to-Equity

: 0.01 (As of Dec. 2023)
View and export this data going back to 2019. Start your Free Trial

InMode's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2.4 Mil. InMode's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $6.6 Mil. InMode's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $787.4 Mil. InMode's debt to equity for the quarter that ended in Dec. 2023 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for InMode's Debt-to-Equity or its related term are showing as below:

INMD' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.01   Max: 0.01
Current: 0.01

During the past 7 years, the highest Debt-to-Equity Ratio of InMode was 0.01. The lowest was 0.00. And the median was 0.01.

INMD's Debt-to-Equity is ranked better than
99.86% of 711 companies
in the Medical Devices & Instruments industry
Industry Median: 0.2 vs INMD: 0.01

InMode Debt-to-Equity Historical Data

The historical data trend for InMode's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMode Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Premium Member Only Premium Member Only - 0.01 0.01 0.01 0.01

InMode Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Competitive Comparison

For the Medical Devices subindustry, InMode's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InMode Debt-to-Equity Distribution

For the Medical Devices & Instruments industry and Healthcare sector, InMode's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where InMode's Debt-to-Equity falls into.



InMode Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

InMode's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

InMode's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InMode  (NAS:INMD) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


InMode Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of InMode's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


InMode (InMode) Business Description

Traded in Other Exchanges
Address
Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, ISR, 2069206
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.